Ambica Agarbathies Aroma & Industries Limited
Ambica Agarbathies Aroma & Industries Limited (AMBICAAGAR.NS) Stock Competitors & Peer Comparison
See (AMBICAAGAR.NS) competitors and their performances in Stock Market.
Peer Comparison Table: Household & Personal Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AMBICAAGAR.NS | ₹22.15 | +7.79% | 380.5M | 30.34 | ₹0.73 | N/A |
| HINDUNILVR.NS | ₹2,064.70 | +0.46% | 4.9T | 48.07 | ₹42.95 | +2.08% |
| HINDUNILVR.BO | ₹2,064.45 | +0.42% | 4.9T | 44.65 | ₹46.24 | +2.08% |
| GODREJCP.NS | ₹997.55 | +1.29% | 1T | 55.98 | ₹17.82 | +1.95% |
| GODREJCP.BO | ₹997.35 | +1.28% | 1T | 56.00 | ₹17.81 | +1.95% |
| MARICO.NS | ₹744.50 | +1.16% | 964.4B | 56.19 | ₹13.25 | +1.41% |
| MARICO.BO | ₹743.25 | +0.95% | 962.7B | 56.31 | ₹13.20 | +1.41% |
| DABUR.BO | ₹415.15 | +1.16% | 736.3B | 40.03 | ₹10.37 | +1.93% |
| DABUR.NS | ₹414.95 | +1.10% | 736B | 39.98 | ₹10.38 | +1.93% |
| COLPAL.NS | ₹1,819.70 | +1.73% | 494.9B | 37.27 | ₹48.83 | +2.80% |
Stock Comparison
AMBICAAGAR.NS vs HINDUNILVR.NS Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, HINDUNILVR.NS has a market cap of 4.9T. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while HINDUNILVR.NS trades at ₹2,064.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas HINDUNILVR.NS's P/E ratio is 48.07. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to HINDUNILVR.NS's ROE of +0.29%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to HINDUNILVR.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check HINDUNILVR.NS's competition here
AMBICAAGAR.NS vs HINDUNILVR.BO Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, HINDUNILVR.BO has a market cap of 4.9T. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while HINDUNILVR.BO trades at ₹2,064.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas HINDUNILVR.BO's P/E ratio is 44.65. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to HINDUNILVR.BO's ROE of +0.29%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to HINDUNILVR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check HINDUNILVR.BO's competition here
AMBICAAGAR.NS vs GODREJCP.NS Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, GODREJCP.NS has a market cap of 1T. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while GODREJCP.NS trades at ₹997.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas GODREJCP.NS's P/E ratio is 55.98. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to GODREJCP.NS's ROE of +0.15%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to GODREJCP.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check GODREJCP.NS's competition here
AMBICAAGAR.NS vs GODREJCP.BO Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, GODREJCP.BO has a market cap of 1T. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while GODREJCP.BO trades at ₹997.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas GODREJCP.BO's P/E ratio is 56.00. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to GODREJCP.BO's ROE of +0.15%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to GODREJCP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check GODREJCP.BO's competition here
AMBICAAGAR.NS vs MARICO.NS Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, MARICO.NS has a market cap of 964.4B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while MARICO.NS trades at ₹744.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas MARICO.NS's P/E ratio is 56.19. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to MARICO.NS's ROE of +0.40%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to MARICO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check MARICO.NS's competition here
AMBICAAGAR.NS vs MARICO.BO Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, MARICO.BO has a market cap of 962.7B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while MARICO.BO trades at ₹743.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas MARICO.BO's P/E ratio is 56.31. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to MARICO.BO's ROE of +0.40%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to MARICO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check MARICO.BO's competition here
AMBICAAGAR.NS vs DABUR.BO Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, DABUR.BO has a market cap of 736.3B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while DABUR.BO trades at ₹415.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas DABUR.BO's P/E ratio is 40.03. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to DABUR.BO's ROE of +0.17%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to DABUR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check DABUR.BO's competition here
AMBICAAGAR.NS vs DABUR.NS Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, DABUR.NS has a market cap of 736B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while DABUR.NS trades at ₹414.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas DABUR.NS's P/E ratio is 39.98. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to DABUR.NS's ROE of +0.17%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to DABUR.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check DABUR.NS's competition here
AMBICAAGAR.NS vs COLPAL.NS Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, COLPAL.NS has a market cap of 494.9B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while COLPAL.NS trades at ₹1,819.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas COLPAL.NS's P/E ratio is 37.27. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to COLPAL.NS's ROE of +0.81%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to COLPAL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check COLPAL.NS's competition here
AMBICAAGAR.NS vs COLPAL.BO Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, COLPAL.BO has a market cap of 493.9B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while COLPAL.BO trades at ₹1,816.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas COLPAL.BO's P/E ratio is 37.15. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to COLPAL.BO's ROE of +0.81%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to COLPAL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check COLPAL.BO's competition here
AMBICAAGAR.NS vs PGHH.BO Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, PGHH.BO has a market cap of 317.7B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while PGHH.BO trades at ₹9,742.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas PGHH.BO's P/E ratio is 44.21. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to PGHH.BO's ROE of +1.01%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to PGHH.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check PGHH.BO's competition here
AMBICAAGAR.NS vs PGHH.NS Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, PGHH.NS has a market cap of 316.4B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while PGHH.NS trades at ₹9,748.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas PGHH.NS's P/E ratio is 44.26. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to PGHH.NS's ROE of +1.01%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to PGHH.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check PGHH.NS's competition here
AMBICAAGAR.NS vs GILLETTE.BO Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, GILLETTE.BO has a market cap of 246B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while GILLETTE.BO trades at ₹7,548.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas GILLETTE.BO's P/E ratio is 46.08. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to GILLETTE.BO's ROE of +0.58%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to GILLETTE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check GILLETTE.BO's competition here
AMBICAAGAR.NS vs GILLETTE.NS Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, GILLETTE.NS has a market cap of 245.6B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while GILLETTE.NS trades at ₹7,538.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas GILLETTE.NS's P/E ratio is 45.98. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to GILLETTE.NS's ROE of +0.58%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to GILLETTE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check GILLETTE.NS's competition here
AMBICAAGAR.NS vs EMAMILTD.NS Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, EMAMILTD.NS has a market cap of 171.8B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while EMAMILTD.NS trades at ₹393.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas EMAMILTD.NS's P/E ratio is 21.61. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to EMAMILTD.NS's ROE of +0.29%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to EMAMILTD.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check EMAMILTD.NS's competition here
AMBICAAGAR.NS vs EMAMILTD.BO Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, EMAMILTD.BO has a market cap of 171.5B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while EMAMILTD.BO trades at ₹392.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas EMAMILTD.BO's P/E ratio is 21.58. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to EMAMILTD.BO's ROE of +0.29%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to EMAMILTD.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check EMAMILTD.BO's competition here
AMBICAAGAR.NS vs CUPID.NS Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, CUPID.NS has a market cap of 116.8B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while CUPID.NS trades at ₹86.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas CUPID.NS's P/E ratio is 140.06. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to CUPID.NS's ROE of +0.24%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to CUPID.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check CUPID.NS's competition here
AMBICAAGAR.NS vs CUPID.BO Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, CUPID.BO has a market cap of 116.6B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while CUPID.BO trades at ₹86.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas CUPID.BO's P/E ratio is 139.82. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to CUPID.BO's ROE of +0.24%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to CUPID.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check CUPID.BO's competition here
AMBICAAGAR.NS vs HONASA.NS Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, HONASA.NS has a market cap of 100B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while HONASA.NS trades at ₹307.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas HONASA.NS's P/E ratio is 64.45. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to HONASA.NS's ROE of +0.13%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to HONASA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check HONASA.NS's competition here
AMBICAAGAR.NS vs HONASA.BO Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, HONASA.BO has a market cap of 99.9B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while HONASA.BO trades at ₹307.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas HONASA.BO's P/E ratio is 64.39. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to HONASA.BO's ROE of +0.13%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to HONASA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check HONASA.BO's competition here
AMBICAAGAR.NS vs JYOTHYLAB.BO Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, JYOTHYLAB.BO has a market cap of 75.6B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while JYOTHYLAB.BO trades at ₹205.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas JYOTHYLAB.BO's P/E ratio is 22.13. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to JYOTHYLAB.BO's ROE of +0.18%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to JYOTHYLAB.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check JYOTHYLAB.BO's competition here
AMBICAAGAR.NS vs JYOTHYLAB.NS Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, JYOTHYLAB.NS has a market cap of 75.5B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while JYOTHYLAB.NS trades at ₹205.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas JYOTHYLAB.NS's P/E ratio is 22.09. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to JYOTHYLAB.NS's ROE of +0.18%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to JYOTHYLAB.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check JYOTHYLAB.NS's competition here
AMBICAAGAR.NS vs BAJAJCON.NS Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, BAJAJCON.NS has a market cap of 47.4B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while BAJAJCON.NS trades at ₹361.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas BAJAJCON.NS's P/E ratio is 31.05. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to BAJAJCON.NS's ROE of +0.22%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to BAJAJCON.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check BAJAJCON.NS's competition here
AMBICAAGAR.NS vs BAJAJCON.BO Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, BAJAJCON.BO has a market cap of 47.3B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while BAJAJCON.BO trades at ₹362.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas BAJAJCON.BO's P/E ratio is 31.05. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to BAJAJCON.BO's ROE of +0.22%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to BAJAJCON.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check BAJAJCON.BO's competition here
AMBICAAGAR.NS vs SHK.NS Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, SHK.NS has a market cap of 17.1B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while SHK.NS trades at ₹123.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas SHK.NS's P/E ratio is 10.02. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to SHK.NS's ROE of +0.13%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to SHK.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check SHK.NS's competition here
AMBICAAGAR.NS vs ALLTIME.NS Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, ALLTIME.NS has a market cap of 13B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while ALLTIME.NS trades at ₹198.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas ALLTIME.NS's P/E ratio is 36.43. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to ALLTIME.NS's ROE of +0.08%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to ALLTIME.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check ALLTIME.NS's competition here
AMBICAAGAR.NS vs BCLIND.NS Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, BCLIND.NS has a market cap of 8.5B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while BCLIND.NS trades at ₹28.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas BCLIND.NS's P/E ratio is 7.28. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to BCLIND.NS's ROE of +0.14%. Regarding short-term risk, AMBICAAGAR.NS is less volatile compared to BCLIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check BCLIND.NS's competition here
AMBICAAGAR.NS vs KAYA.NS Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, KAYA.NS has a market cap of 3.8B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while KAYA.NS trades at ₹249.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas KAYA.NS's P/E ratio is -4.39. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to KAYA.NS's ROE of +0.62%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to KAYA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check KAYA.NS's competition here
AMBICAAGAR.NS vs KAYA.BO Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, KAYA.BO has a market cap of 3.8B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while KAYA.BO trades at ₹248.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas KAYA.BO's P/E ratio is -4.37. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to KAYA.BO's ROE of +0.62%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to KAYA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check KAYA.BO's competition here
AMBICAAGAR.NS vs ADORMUL.BO Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, ADORMUL.BO has a market cap of 1.3B. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while ADORMUL.BO trades at ₹135.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas ADORMUL.BO's P/E ratio is -29.80. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to ADORMUL.BO's ROE of -0.32%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to ADORMUL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check ADORMUL.BO's competition here
AMBICAAGAR.NS vs PCCOSMA.BO Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, PCCOSMA.BO has a market cap of 835.8M. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while PCCOSMA.BO trades at ₹315.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas PCCOSMA.BO's P/E ratio is 10.43. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to PCCOSMA.BO's ROE of +0.16%. Regarding short-term risk, AMBICAAGAR.NS is less volatile compared to PCCOSMA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check PCCOSMA.BO's competition here
AMBICAAGAR.NS vs JHS.BO Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, JHS.BO has a market cap of 630.2M. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while JHS.BO trades at ₹7.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas JHS.BO's P/E ratio is -7.92. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to JHS.BO's ROE of -0.03%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to JHS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check JHS.BO's competition here
AMBICAAGAR.NS vs JHS.NS Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, JHS.NS has a market cap of 618.9M. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while JHS.NS trades at ₹7.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas JHS.NS's P/E ratio is -11.48. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to JHS.NS's ROE of -0.03%. Regarding short-term risk, AMBICAAGAR.NS is less volatile compared to JHS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check JHS.NS's competition here
AMBICAAGAR.NS vs STDSFAC.BO Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, STDSFAC.BO has a market cap of 420.9M. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while STDSFAC.BO trades at ₹50.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas STDSFAC.BO's P/E ratio is N/A. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to STDSFAC.BO's ROE of N/A. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to STDSFAC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check STDSFAC.BO's competition here
AMBICAAGAR.NS vs NKIND.BO Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, NKIND.BO has a market cap of 396.7M. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while NKIND.BO trades at ₹66.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas NKIND.BO's P/E ratio is -6.41. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to NKIND.BO's ROE of +0.02%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to NKIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check NKIND.BO's competition here
AMBICAAGAR.NS vs AMBICAAGAR.BO Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, AMBICAAGAR.BO has a market cap of 389.9M. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while AMBICAAGAR.BO trades at ₹22.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas AMBICAAGAR.BO's P/E ratio is 78.28. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to AMBICAAGAR.BO's ROE of +0.01%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to AMBICAAGAR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check AMBICAAGAR.BO's competition here
AMBICAAGAR.NS vs NKIND.NS Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, NKIND.NS has a market cap of 366.6M. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while NKIND.NS trades at ₹61.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas NKIND.NS's P/E ratio is -5.92. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to NKIND.NS's ROE of +0.02%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to NKIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check NKIND.NS's competition here
AMBICAAGAR.NS vs NUWAY.BO Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, NUWAY.BO has a market cap of 354.6M. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while NUWAY.BO trades at ₹37.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas NUWAY.BO's P/E ratio is 14.40. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to NUWAY.BO's ROE of N/A. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to NUWAY.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check NUWAY.BO's competition here
AMBICAAGAR.NS vs PAOS.BO Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, PAOS.BO has a market cap of 292.4M. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while PAOS.BO trades at ₹47.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas PAOS.BO's P/E ratio is -9.05. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to PAOS.BO's ROE of +0.22%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to PAOS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check PAOS.BO's competition here
AMBICAAGAR.NS vs SATTVASUKU.BO Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, SATTVASUKU.BO has a market cap of 276.2M. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while SATTVASUKU.BO trades at ₹0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas SATTVASUKU.BO's P/E ratio is -72.00. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to SATTVASUKU.BO's ROE of +0.09%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to SATTVASUKU.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check SATTVASUKU.BO's competition here
AMBICAAGAR.NS vs PARMCOS-B.BO Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, PARMCOS-B.BO has a market cap of 174.8M. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while PARMCOS-B.BO trades at ₹36.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas PARMCOS-B.BO's P/E ratio is 171.43. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to PARMCOS-B.BO's ROE of +0.00%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to PARMCOS-B.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check PARMCOS-B.BO's competition here
AMBICAAGAR.NS vs HIPOLIN.BO Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, HIPOLIN.BO has a market cap of 153.8M. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while HIPOLIN.BO trades at ₹49.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas HIPOLIN.BO's P/E ratio is -4.91. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to HIPOLIN.BO's ROE of -0.35%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to HIPOLIN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check HIPOLIN.BO's competition here
AMBICAAGAR.NS vs CORNE.BO Comparison April 2026
AMBICAAGAR.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBICAAGAR.NS stands at 380.5M. In comparison, CORNE.BO has a market cap of 49.1M. Regarding current trading prices, AMBICAAGAR.NS is priced at ₹22.15, while CORNE.BO trades at ₹9.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBICAAGAR.NS currently has a P/E ratio of 30.34, whereas CORNE.BO's P/E ratio is -5.78. In terms of profitability, AMBICAAGAR.NS's ROE is +0.01%, compared to CORNE.BO's ROE of +0.09%. Regarding short-term risk, AMBICAAGAR.NS is more volatile compared to CORNE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for AMBICAAGAR.NS.Check CORNE.BO's competition here